201 related articles for article (PubMed ID: 33058920)
1. Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice.
Cao D; Jia Z; Wu Y; Su T; Zhao D; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Dec; 263():118580. PubMed ID: 33058920
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
3. TET-mediated DNA demethylation plays an important role in arsenic-induced HBE cells oxidative stress via regulating promoter methylation of OGG1 and GSTP1.
Wang Q; Wang W; Zhang A
Toxicol In Vitro; 2021 Apr; 72():105075. PubMed ID: 33388378
[TBL] [Abstract][Full Text] [Related]
4. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.
Ko M; An J; Bandukwala HS; Chavez L; Aijö T; Pastor WA; Segal MF; Li H; Koh KP; Lähdesmäki H; Hogan PG; Aravind L; Rao A
Nature; 2013 May; 497(7447):122-6. PubMed ID: 23563267
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
[TBL] [Abstract][Full Text] [Related]
6. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
7. Mediation of the malignant biological characteristics of gastric cancer cells by the methylated CpG islands in RNF180 DNA promoter.
Deng J; Guo J; Guo X; Hou Y; Xie X; Sun C; Zhang R; Yu X; Liang H
Oncotarget; 2016 Jul; 7(28):43461-43474. PubMed ID: 27223257
[TBL] [Abstract][Full Text] [Related]
8. Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation.
Sohni A; Bartoccetti M; Khoueiry R; Spans L; Vande Velde J; De Troyer L; Pulakanti K; Claessens F; Rao S; Koh KP
Mol Cell Biol; 2015 Mar; 35(6):1026-42. PubMed ID: 25582196
[TBL] [Abstract][Full Text] [Related]
9. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.
Schoeler K; Aufschnaiter A; Messner S; Derudder E; Herzog S; Villunger A; Rajewsky K; Labi V
FEBS J; 2019 Sep; 286(18):3566-3581. PubMed ID: 31120187
[TBL] [Abstract][Full Text] [Related]
10. Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
Kamdar S; Isserlin R; Van der Kwast T; Zlotta AR; Bader GD; Fleshner NE; Bapat B
Clin Epigenetics; 2019 Mar; 11(1):54. PubMed ID: 30917865
[TBL] [Abstract][Full Text] [Related]
11. Altering TET dioxygenase levels within physiological range affects DNA methylation dynamics of HEK293 cells.
Grosser C; Wagner N; Grothaus K; Horsthemke B
Epigenetics; 2015; 10(9):819-33. PubMed ID: 26186463
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
[TBL] [Abstract][Full Text] [Related]
13. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics in gastric carcinogenesis: TET genes as important players.
Necula LG; Mambet C; Albulescu R; Diaconu CC
J Immunoassay Immunochem; 2015; 36(5):445-55. PubMed ID: 25714048
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of Atp4a concomitant with intragenic DNA demethylation for cancer inhibition in a gastric cancer model.
Cao D; Zhao D; Jia Z; Su T; Zhang Y; Wu Y; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
Life Sci; 2020 Feb; 242():117214. PubMed ID: 31884095
[TBL] [Abstract][Full Text] [Related]
16. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic Acid Promotes
Wu CY; Zhang B; Kim H; Anderson SK; Miller JS; Cichocki F
J Immunol; 2020 Sep; 205(6):1513-1523. PubMed ID: 32759296
[TBL] [Abstract][Full Text] [Related]
18. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression.
Reimer M; Pulakanti K; Shi L; Abel A; Liang M; Malarkannan S; Rao S
BMC Dev Biol; 2019 Jul; 19(1):16. PubMed ID: 31286885
[TBL] [Abstract][Full Text] [Related]
20. TET2 Promoter DNA Methylation and Expression in Childhood Acute Lymphoblastic Leukemia.
Bahari G; Hashemi M; Naderi M; Taheri M
Asian Pac J Cancer Prev; 2016; 17(8):3959-62. PubMed ID: 27644645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]